Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 166 AL 180

Accelerating Alzheimer's disease drug discovery and development: what's the way forward?

Imbimbo BP, Ippati S, Watling M, Balducci C.

Expert Opin Drug Discov. 2021 Jul;16(7):727-735. doi: 10.1080/17460441.2021.1887132. Epub 2021 Mar 2.

Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer's disease risk

Shigemizu D, Mitsumori R, Akiyama S, Miyashita A, Morizono T, Higaki S, Asanomi Y, Hara N, Tamiya G, Kinoshita K, Ikeuchi T, Niida S, Ozaki K.

Transl Psychiatry. 2021 Mar 3;11(1):151. doi: 10.1038/s41398-021-01272-3.

In Quest of Tablet Apps for Elders With Alzheimer's Disease: A Descriptive Review

Tak SH.

Comput Inform Nurs. 2021 Mar 3;39(7):347-354. doi: 10.1097/CIN.0000000000000718.

A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease

Singh YP, Rai H, Singh G, Singh GK, Mishra S, Kumar S, Srikrishna S, Modi G.

Eur J Med Chem. 2021 Apr 5;215:113278. doi: 10.1016/j.ejmech.2021.113278. Epub 2021 Feb 15.

Promotion and Inhibition of Amyloid-β Peptide Aggregation: Molecular Dynamics Studies

Itoh SG, Okumura H.

Int J Mol Sci. 2021 Feb 13;22(4):1859. doi: 10.3390/ijms22041859.

Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer's Disease Therapy

Arya A, Chahal R, Rao R, Rahman MH, Kaushik D, Akhtar MF, Saleem A, Khalifa SMA, El-Seedi HR, Kamel M, Albadrani GM, Abdel-Daim MM, Mittal V.

Biomolecules. 2021 Feb 25;11(3):350. doi: 10.3390/biom11030350.

The Neurovascular Unit Dysfunction in Alzheimer's Disease

Soto-Rojas LO, Pacheco-Herrero M, Martínez-Gómez PA, Campa-Córdoba BB, Apátiga-Pérez R, Villegas-Rojas MM, Harrington CR, de la Cruz F, Garcés-Ramírez L, Luna-Muñoz J.

Int J Mol Sci. 2021 Feb 18;22(4):2022. doi: 10.3390/ijms22042022.

Participation of Amyloid and Tau Protein in Post-Ischemic Neurodegeneration of the Hippocampus of a Nature Identical to Alzheimer's Disease

Pluta R, Ouyang L, Januszewski S, Li Y, Czuczwar SJ.

Int J Mol Sci. 2021 Feb 28;22(5):2460. doi: 10.3390/ijms22052460.

Mast Cell and Astrocyte Hemichannels and Their Role in Alzheimer's Disease, ALS, and Harmful Stress Conditions

Harcha PA, Garcés P, Arredondo C, Fernández G, Sáez JC, van Zundert B.

Int J Mol Sci. 2021 Feb 15;22(4):1924. doi: 10.3390/ijms22041924.

The 'a, b, c's of pretangle tau and their relation to aging and the risk of Alzheimer's Disease

Harley CW, Walling SG, Yuan Q, Martin GM.

Semin Cell Dev Biol. 2021 Aug;116:125-134. doi: 10.1016/j.semcdb.2020.12.010. Epub 2021 Mar 2.

Value-Generating Exploratory Trials in Neurodegenerative Dementias

Friedman LG, McKeehan N, Hara Y, Cummings JL, Matthews DC, Zhu J, Mohs RC, Wang D, Hendrix SB, Quintana M, Schneider LS, Grundman M, Dickson SP, Feldman HH, Jaeger J, Finger EC, Ryan JM, Niehoff D, Dickinson SL, Markowitz JT, Owen M, Travaglia A, Fillit HM.

Neurology. 2021 May 18;96(20):944-954. doi: 10.1212/WNL.0000000000011774. Epub 2021 Mar 5.

Roles and Mechanisms of Axon-Guidance Molecules in Alzheimer's Disease

Zhang L, Qi Z, Li J, Li M, Du X, Wang S, Zhou G, Xu B, Liu W, Xi S, Xu Z, Deng Y.

Mol Neurobiol. 2021 Jul;58(7):3290-3307. doi: 10.1007/s12035-021-02311-2. Epub 2021 Mar 5.

Common Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer's Disease

Rossi B, Santos-Lima B, Terrabuio E, Zenaro E, Constantin G.

Front Immunol. 2021 Feb 19;12:639369. doi: 10.3389/fimmu.2021.639369. eCollection 2021.

Biomaterials in treatment of Alzheimer's disease

Agrawal M, Prathyusha E, Ahmed H, Dubey SK, Kesharwani P, Singhvi G, Naidu VGM, Alexander A.

Neurochem Int. 2021 May;145:105008. doi: 10.1016/j.neuint.2021.105008. Epub 2021 Mar 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias